|
1
|
Komotar RJ, Otten ML, Moise G and Connolly
ES Jr: Radiotherapy plus concomitant and adjuvant temozolomide for
glioblastoma-a critical review. Clin Med Oncol. 2:421–422.
2008.PubMed/NCBI
|
|
2
|
Minniti G, De Sanctis V, Muni R, et al:
Radiotherapy plus concomitant and adjuvant temozolomide for
glioblastoma in elderly patients. J Neurooncol. 88:97–103. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stupp R, Mason WP, van den Bent MJ, et al:
Radiotherapy plus concomitant and adjuvant temozolomide for
glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen SM, Chen HC, Chen SJ, et al:
MicroRNA-495 inhibits proliferation of glioblastoma multiforme
cells by downregulating cyclin-dependent kinase 6. World J Surg
Oncol. 11:872013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Furnari FB, Fenton T, Bachoo RM, et al:
Malignant astrocytic glioma: genetics, biology, and paths to
treatment. Genes Dev. 21:2683–2710. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rich JN, Hans C, Jones B, et al: Gene
expression profiling and genetic markers in glioblastoma survival.
Cancer Res. 65:4051–4058. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Feng J, Zhang X, Zhu H, Wang X, Ni S and
Huang J: High expression of FoxP1 is associated with improved
survival in patients with non-small cell lung cancer. Am J Clin
Pathol. 138:230–235. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Koon HB, Ippolito GC, Banham AH and Tucker
PW: FOXP1: a potential therapeutic target in cancer. Expert Opin
Ther Targets. 11:955–965. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Green MR, Gandhi MK, Courtney MJ, Marlton
P and Griffiths L: Relative abundance of full-length and truncated
FOXP1 isoforms is associated with differential NFkappaB activity in
Follicular Lymphoma. Leuk Res. 33:1699–1702. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hu H, Wang B, Borde M, et al: Foxp1 is an
essential transcriptional regulator of B cell development. Nat
Immunol. 7:819–826. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shu W, Lu MM, Zhang Y, Tucker PW, Zhou D
and Morrisey EE: Foxp2 and Foxp1 cooperatively regulate lung and
esophagus development. Development. 134:1991–2000. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wlodarska I, Veyt E, De Paepe P, et al:
FOXP1, a gene highly expressed in a subset of diffuse large B-cell
lymphoma, is recurrently targeted by genomic aberrations. Leukemia.
19:1299–1305. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lenz G, Wright GW, Emre NC, et al:
Molecular subtypes of diffuse large B-cell lymphoma arise by
distinct genetic pathways. Proc Natl Acad Sci USA. 105:13520–13525.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Adams H, Tzankov A, Lugli A and Zlobec I:
New time-dependent approach to analyse the prognostic significance
of immunohistochemical biomarkers in colon cancer and diffuse large
B-cell lymphoma. J Clin Pathol. 62:986–997. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hoeller S, Schneider A, Haralambieva E,
Dirnhofer S and Tzankov A: FOXP1 protein overexpression is
associated with inferior outcome in nodal diffuse large B-cell
lymphomas with non-germinal centre phenotype, independent of gains
and structural aberrations at 3p14.1. Histopathology. 57:73–80.
2010. View Article : Google Scholar
|
|
16
|
Giatromanolaki A, Koukourakis MI, Sivridis
E, Gatter KC, Harris AL and Banham AH: Loss of expression and
nuclear/cytoplasmic localization of the FOXP1 forkhead
transcription factor are common events in early endometrial cancer:
relationship with estrogen receptors and HIF-1alpha expression. Mod
Pathol. 19:9–16. 2006. View Article : Google Scholar
|
|
17
|
Bates GJ, Fox SB, Han C, et al: Expression
of the forkhead transcription factor FOXP1 is associated with that
of estrogen receptor-beta in primary invasive breast carcinomas.
Breast Cancer Res Treat. 111:453–459. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Takayama K, Horie-Inoue K, Ikeda K, et al:
FOXP1 is an androgen-responsive transcription factor that
negatively regulates androgen receptor signaling in prostate cancer
cells. Biochem Biophys Res Commun. 374:388–393. 2008. View Article : Google Scholar
|
|
19
|
Toma MI, Weber T, Meinhardt M, et al:
Expression of the Forkhead transcription factor FOXP1 is associated
with tumor grade and Ki67 expression in clear cell renal cell
carcinoma. Cancer Invest. 29:123–129. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fox SB, Brown P, Han C, et al: Expression
of the forkhead transcription factor FOXP1 is associated with
estrogen receptor alpha and improved survival in primary human
breast carcinomas. Clin Cancer Res. 10:3521–3527. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wei KC, Huang CY, Chen PY, et al:
Evaluation of the prognostic value of CD44 in glioblastoma
multiforme. Anticancer Res. 30:253–259. 2010.PubMed/NCBI
|
|
22
|
Barbaric D, Dalla-Pozza L and Byrne JA: A
reliable method for total RNA extraction from frozen human bone
marrow samples taken at diagnosis of acute leukaemia. J Clin
Pathol. 55:865–867. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kelleher KL, Leck KJ, Hendry IA and
Matthaei KI: A one-step quantitative reverse transcription
polymerase chain reaction procedure. Brain Res Brain Res Protoc.
6:100–107. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Su F, Li H, Yan C, Jia B, Zhang Y and Chen
X: Depleting MEKK1 expression inhibits the ability of invasion and
migration of human pancreatic cancer cells. J Cancer Res Clin
Oncol. 135:1655–1663. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li C and Tucker PW: DNA-binding properties
and secondary structural model of the hepatocyte nuclear factor
3/fork head domain. Proc Natl Acad Sci USA. 90:11583–11587. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Banham AH, Beasley N, Campo E, et al: The
FOXP1 winged helix transcription factor is a novel candidate tumor
suppressor gene on chromosome 3p. Cancer Res. 61:8820–8829.
2001.PubMed/NCBI
|
|
27
|
Shi C, Sakuma M, Mooroka T, et al:
Down-regulation of the forkhead transcription factor Foxp1 is
required for monocyte differentiation and macrophage function.
Blood. 112:4699–4711. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang Y, Li S, Yuan L, et al: Foxp1
coordinates cardiomyocyte proliferation through both
cell-autonomous and nonautonomous mechanisms. Gen Dev.
24:1746–1757. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Banham AH, Boddy J, Launchbury R, et al:
Expression of the forkhead transcription factor FOXP1 is associated
both with hypoxia inducible factors (HIFs) and the androgen
receptor in prostate cancer but is not directly regulated by
androgens or hypoxia. Prostate. 67:1091–1098. 2007. View Article : Google Scholar
|
